AuthorWrite something about yourself. No need to be fancy, just an overview. ArchivesCategories |
Back to Blog
Aural analytics3/15/2023 The Aural Analytics Speech Vitals tool provides validated metrics reflecting the neurological and respiratory health of users and enables clinical-grade speech collection and near-real-time cloud-based analytics. Medable is integrating Aural Analytics' innovative speech application with its decentralized clinical trial platform, to capture speech patterns remotely. Medable and Aural Analytics’ technologies will continuously collect data using iPhone applications and Apple watches to understand a variety of physical and physiological parameters as they pertain to a participant’s perceived level of fatigue and physical capabilities for instance, speech provides rich information about health. IOG: The NIH-funded work, titled “Digital BioMarkers for Care,” is to test and develop remote digital data tools designed to assess the wellbeing of patients undergoing cancer treatment. OSP: Please feel free to share as much detail as you can about what Medable and Aural Analytics will be bringing to the table. The National Cancer Institute coordinates the US National Cancer Program and is part of the NIH, which is one of eleven agencies that are part of the US Department of Health and Human Services. IOG: Medable applied for and won a Small Business Innovation Research award that is a designated part of the National Cancer Institute’s Cancer Moonshot program. ![]() Ingrid Oakley-Girvan, SVP of research and academics, Medable OSP: Could you please tell us how Medable came to be involved with the Cancer Moonshot program? Ingrid Oakley-Girvan, Medable’s senior vice president of research and academics, spoke with Outsourcing-Pharma about the program, the company’s work connected to the Cancer Moonshot program, and how the work provides hope for cancer patients and caregivers. To date, 240 research projects across more than 70 initiatives have been supported by Moonshot funding, with Medable receiving its funding in 2018. The initiative has infused an additional $1.8b USD into cancer research, through the 21st Century Cures Act. This year is the fifth anniversary of the launch of the National Institute of Health’s (NIH’s) Beau Biden Cancer Moonshot program, a seven-year initiative named in honor of President Joe Biden’s late son. ![]() The collaboration will use Aural Analytics technology (as well as other remote data capture solutions) to track oncology patients’ health, using Medable’s platform for decentralized trials. Patient-centric drug development tech firm Medable is partnering with Aural Analytics, which offers clinical-grade speech collection and analytical tools, to assess remote data capture and digital biomarkers in cancer patients in an effort connected to Medable’s Cancer Moonshot work.
0 Comments
Read More
Leave a Reply. |